Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aesculap AG
- Trial code
- NCT05547984
- Record updated
- 12 November 2026
- Original description
A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cupRead full original descriptionShow less
A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup
A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup
Inclusion: Primary coxarthrosis patients indicated for cementless total hip arthroplasty; Written informed patient consent.
Exclusion: Hip trauma or revision surgery; Ongoing oncologic therapy; Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period; Rheumatoid or neurologic disease; Preoperatively elevated Co or Cr serum levels >1.0 µg/L; Patients <18 years at surgery; BMI >35; Acetabular cup size <52 expected; Patients not able to mentally or physically comply with the study demands and follow-up visits; Pregnancy.